1. Effects of omega-3 fatty acid supplementation on the risk of atrial fibrillation (AF) and micro-AF in the OMEMI trial. (3rd October 2022) Authors: Myhre, P; Berge, T; Kalstad, A; Tveit, S H; Laake, K; Schmidt, E B; Solheim, S; Arnesen, H; Seljeflot, I; Tveit, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Screen-detected atrial fibrillation (AF) and "micro-AF" after myocardial infarction in patients 70–82 years and risk of cardiovascular events in the OMEMI trial. (3rd October 2022) Authors: Berge, T; Myhre, P L; Kalstad, A A; Laake, K; Tveit, S H; Onarheim, S; Solheim, S; Seljeflot, I; Arnesen, H; Tveit, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗